Jian Xie

President and Chief Operating OfficeratFulgent Genetics· In proxies 2021–2025

Pay in FY2025+18% from the year before · Fulgent Genetics stock +42.2% the same year

Jian Xie was paid $2.8M in FY2025 (Dec), up 18%. Fulgent Genetics stock rose 42.2% that year.

Pay$100 in the stock at the end of FY20 → $50

Pay is from the Summary Compensation Table of each Fulgent Genetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

FLGT
Fulgent GeneticsPublic company · 5 yr
- President and Chief Operating Officer2021 – Present · 5 yrStock in role -53%

Roles come from the proxy statements of each company.

Activity

Pay
Fulgent Genetics COO pay rose 18% to $2.8M. The stock rose 42% in FY2025 (Dec).
DEF 14AMar 31, 2026
Pay
Fulgent Genetics COO pay rose 33% to $2.4M. The stock fell 36% in FY2024 (Dec).
DEF 14AMar 25, 2025
Pay
Fulgent Genetics COO pay fell 54% to $1.8M. The stock fell 3% in FY2023 (Dec).
DEF 14AMar 27, 2024
Pay
Fulgent Genetics COO pay rose 449% to $3.9M. The stock fell 70% in FY2022 (Dec).
DEF 14AMar 27, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?